These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten. Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Fiche M, Gautherot E, Barbet J, Chatal JF. J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353 [Abstract] [Full Text] [Related]
4. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments. Obradovic V, Artiko V, Petrovic M, Stefanovic B, Krivokapic Z, Zuvela M, Stojkovic M, Stefanovic B, Milovanovic A, Vlajkovic M. Hepatogastroenterology; 2006 Sep; 53(70):526-30. PubMed ID: 16995454 [Abstract] [Full Text] [Related]
8. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer. Watanabe N, Oriuchi N, Endo K, Inoue T, Kuroki M, Matsuoka Y, Tanada S, Murata H, Kim EE, Sasaki Y. J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120 [Abstract] [Full Text] [Related]
11. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB. Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754 [Abstract] [Full Text] [Related]
12. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments. Yazaki PJ, Wu AM, Tsai SW, Williams LE, Ikler DN, Wong JY, Shively JE, Raubitschek AA. Bioconjug Chem; 2001 Oct; 12(2):220-8. PubMed ID: 11312683 [Abstract] [Full Text] [Related]
13. Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer. Ychou M, Pelegrin A, Faurous P, Robert B, Saccavini JC, Guerreau D, Rossi JF, Fabbro M, Buchegger F, Mach JP, Artus JC. Int J Cancer; 1998 Feb 09; 75(4):615-9. PubMed ID: 9466665 [Abstract] [Full Text] [Related]
14. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF. Nucl Med Biol; 1993 May 09; 20(4):443-52. PubMed ID: 8504286 [Abstract] [Full Text] [Related]
15. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. Faivre-Chauvet A, Gestin JF, Mease RC, Sai-Maurel C, Thédrez P, Slinkin M, Meinken GE, Srivastava SC, Chatal JF. Nucl Med Biol; 1993 Aug 09; 20(6):763-71. PubMed ID: 8401377 [Abstract] [Full Text] [Related]
16. Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. Devys A, Thedrez P, Gautherot E, Faivre-Chauvet A, Saï-Maurel C, Rouvier E, Auget JL, Barbet J, Chatal JF. Int J Cancer; 1996 Sep 17; 67(6):883-91. PubMed ID: 8824563 [Abstract] [Full Text] [Related]
17. Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. Kraeber-Bodéré F, Faivre-Chauvet A, Saï-Maurel C, Campion L, Fiche M, Gautherot E, Le Boterff J, Barbet J, Chatal JF, Thédrez P. Clin Cancer Res; 1999 Oct 17; 5(10 Suppl):3183s-3189s. PubMed ID: 10541362 [Abstract] [Full Text] [Related]
18. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. Macmillan CH, Perkins AC, Wastie ML, Leach IH, Morgan DA. Br J Cancer; 1993 Jun 17; 67(6):1391-4. PubMed ID: 8390288 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of 111In-labelled monoclonal antibody ZCE-025 and fragments in tumour-bearing mice. Koziol JA, Lee PP, Dillman RO, Fagnani R, Halpern SE. Nucl Med Commun; 1995 Apr 17; 16(4):299-305. PubMed ID: 7624111 [Abstract] [Full Text] [Related]